Patents by Inventor Michael Nelboeck-Hochstetter

Michael Nelboeck-Hochstetter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5026706
    Abstract: Naftopidil,1-(2-methoxyphenyl)-4-[3-(naphth-1-yloxy)-2-hydroxypropyl)]-pipe razine, or of a salt thereof, is effective in the treatment of dysuria, particularly in causes of prostatic hypertrophy.
    Type: Grant
    Filed: May 30, 1990
    Date of Patent: June 25, 1991
    Assignee: Boehringer Mannheim GmbH
    Inventors: Gisbert Sponer, Ulrich Reicke, Michael Nelboeck-Hochstetter
  • Patent number: 4248786
    Abstract: New hydroxy-succinimide ester compounds of the formula ##STR1## wherein X is selected from a carboxy-succinimide ester group and radicals of the general formulae: ##STR2## A is -O-CH.sub.2 -CH.sub.2 when n is 2 and X is a succinimide ester group but otherwise is a single bond;n is a whole number of from 2 to 7;m is 1, 2, 3 or 4,R is hydrogen, methyl, or cyanide; andR' is methyl or ethyl.have been found outstandingly useful as bridge-building compounds for linking proteins, especially biologically active proteins, to solid or liquid carrier matrix materials, thereby yielding valuable carrier-bound enzymatically active protein compositions.
    Type: Grant
    Filed: March 8, 1979
    Date of Patent: February 3, 1981
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hans-Georg Batz, Jurgen Horn, Klaus Stellner, Josef Maier, Michael Nelboeck-Hochstetter, Gunter Weimann
  • Patent number: 4181575
    Abstract: In a process for the determination of total or bound cholesterol by liberating any bound cholesterol using cholesterol esterase and simultaneously or subsequently determining the liberated cholesterol and any initially free cholesterol with a cholesterol reacting enzyme, the improvement comprising using as the cholesterol reacting enzyme an NAD or NADP-dependent cholesterol dehydrogenase obtained from an anaerobic microorganism, e.g., Eubacterium sp. ATCC 21408, or from mammalian tissue, e.g., liver.
    Type: Grant
    Filed: October 13, 1977
    Date of Patent: January 1, 1980
    Assignee: Boehringer Mannheim GmbH
    Inventors: Wolfgang Gruber, Gunter Lang, Michael Nelboeck-Hochstetter, Peter Roeschlau, Hans Seidel, Detlef von Hoerschelmann
  • Patent number: 4155914
    Abstract: New hydroxy-succinimide ester compounds of the formula ##STR1## wherein X is selected from a carboxy-succinimide ester group and radicals of the general formulae: ##STR2## A is --O--CH.sub.2 --CH.sub.2 when n is 2 and X is a succinimide ester group but otherwise is a single bond;N is a whole number of from 2 to 7;M is 1, 2, 3 or 4,R is hydrogen, methyl, or cyanide; andR' is methyl or ethyl;Have been found outstandingly useful as bridge-building compounds for linking proteins, especially biologically active proteins, to solid or liquid carrier matrix materials, thereby yielding valuable carrier-bound enzymatically active protein compositions.
    Type: Grant
    Filed: July 13, 1977
    Date of Patent: May 22, 1979
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hans-Georg Batz, Jurgen Horn, Klaus Stellner, Josef Maier, Michael Nelboeck-Hochstetter, Gunter Weimann
  • Patent number: 4148994
    Abstract: Crystalline salts of .beta.-nicotinamide-adenine-dinucleotide (.beta.-NAD), particularly alkali metal salts thereof are prepared in good yield and high quality to provide an analytically useful .beta.-NAD form.
    Type: Grant
    Filed: December 27, 1976
    Date of Patent: April 10, 1979
    Assignee: Boehringer Mannheim GmbH
    Inventors: Klaus Muhlegger, Gunter Weimann, Michael Nelboeck-Hochstetter
  • Patent number: 4008127
    Abstract: Cholesterol oxidase which oxidizes cholesterol with oxygen to give cholestenone and hydrogen peroxide, is prepared by culturing Nocardia erthropolis ATCC 17895, Nocardia erthropolis ATCC 4277, Nocardia formica ATCC 14811 or Proactinomyce erythropolis NCIB 9158 first on a peptone-containing mineral salt medium and thereafter on at least one sterol compound as the sole source of carbon, and then isolating the cholesterol oxidase formed from the cultured micro-organism, wherein said sterol compound is of the formula ##STR1## in which R.sub.1 and R.sub.2 are hydrogen or together represent a double bond,R.sub.3 and R.sub.4 are hydrogen or together represent a double bond, andR.sub.5 is hydrogen or alkyl containing up to 3 carbon atoms.
    Type: Grant
    Filed: November 20, 1975
    Date of Patent: February 15, 1977
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Wolfgang Gruber, Hans Ulrich Bergmeyer, Michael Nelboeck-Hochstetter, Klaus Beaucamp, Gunter Holz, Johanna Gramsall, Gunter Lang